Large-scale testing (Phase 3)Study completedNCT00260832What this trial is testingTrial of Decitabine in Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Eisai Inc. 485
Early research (Phase 1)Study completedNCT04714372What this trial is testingFT538 in Combination With Daratumumab in AML Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaMyeloid LeukemiaMonocytic Leukemia Masonic Cancer Center, University of Minnesota 9
Very early researchLooking for participantsNCT06398457What this trial is testingDarzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific AntibodiesWho this might be right forHematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableUnknownNCT03450512What this trial is testingIncidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive TherapyWho this might be right forAcute Myeloid Leukemia Centre Hospitalier Universitaire, Amiens 170
Testing effectiveness (Phase 2)Ended earlyNCT02418000What this trial is testingE6201 for the Treatment of Advanced Hematologic Malignancies With FLT3 and/or Ras MutationsWho this might be right forAMLMDSCMML Spirita Oncology, LLC 27
Not applicableLooking for participantsNCT06782971What this trial is testingEvaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDXWho this might be right forAML - Acute Myeloid Leukemia Clinical Hub for Interventional Research (CHOIR) 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06684509What this trial is testingAtorvaststin and Cardiotoxicity in Acute Myloid LeukemiaWho this might be right forLeukemiaHodgkin Disease Assiut University 46
Early research (Phase 1)Study completedNCT03358719What this trial is testingDEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaBlasts 30 Percent or Less of Bone Marrow Nucleated CellsChronic Myelomonocytic Leukemia+3 more Roswell Park Cancer Institute 8
Not applicableUnknownNCT01106144What this trial is testingGenetic Predictive Model Based on Single Nucleotide Polymorphisms in the DNA Repair Pathway and Drug Metabolis/Transport Pharmacogenetics in the Prediction of Response and Treatment Outcomes in Acute Myeloid LeukemiaWho this might be right forPatients With Acute Myeloid LeukemiaPatients Receiving Induction/Consolidation Chemotherapy Samsung Medical Center 500
Not applicableStudy completedNCT00602134What this trial is testingBioequivalence Study of 6-Mercaptopurine Under Fasting ConditionsWho this might be right forAcute Lymphoblastic Leukemia Roxane Laboratories 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313852What this trial is testingInotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaWho this might be right forB-cell Acute Lymphoblastic LeukemiaB-Cell Acute Lymphoblastic Leukemia, AdultB-ALL Memorial Sloan Kettering Cancer Center 26
Not applicableStudy completedNCT00899652What this trial is testingDNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaWho this might be right forLeukemia Children's Oncology Group 149
Not applicableStudy completedNCT02921815What this trial is testingAnalyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid TreatmentWho this might be right forMyelodysplastic SyndromesLeukemia, Myeloid, Acute Celgene 84
Testing effectiveness (Phase 2)UnknownNCT04731974What this trial is testingAcute Concussion and MelatoninWho this might be right forConcussion, MildConcussion, BrainPediatric ALL Children's National Research Institute 254
Large-scale testing (Phase 3)Study completedNCT00430118What this trial is testingCombination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaWho this might be right forLeukemia University Hospital Schleswig-Holstein 4,559
Large-scale testing (Phase 3)UnknownNCT03553238What this trial is testingPrecision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLWho this might be right forLeukemia, AcuteLeukemia, T CellLeukemia, Lymphoblastic Nanfang Hospital, Southern Medical University 70
Post-approval studies (Phase 4)Study completedNCT00198991What this trial is testingGerman Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)Who this might be right forAdult Acute Lymphocytic Leukemia Goethe University 1,883
Testing effectiveness (Phase 2)Study completedNCT02362035What this trial is testingACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic MalignanciesWho this might be right forFollicular Lymphoma (FL)CLLSmall Lymphocytic Lymphoma (SLL)+10 more Acerta Pharma BV 161
Early research (Phase 1)Looking for participantsNCT06366789What this trial is testingDose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAML With Gene Mutations Lomond Therapeutics Holdings, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT01912274What this trial is testingSafety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia Helsinn Healthcare SA 50